ICL Price To Sales Ratio vs Payout Ratio Analysis

ICL Stock

USD 5.02 0.07 1.38%

ICL Israel financial indicator trend analysis is infinitely more than just investigating ICL Israel Chemicals recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether ICL Israel Chemicals is a good investment. Please check the relationship between ICL Israel Price To Sales Ratio and its Payout Ratio accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICL Israel Chemicals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Price To Sales Ratio vs Payout Ratio

Price To Sales Ratio vs Payout Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of ICL Israel Chemicals Price To Sales Ratio account and Payout Ratio. At this time, the significance of the direction appears to have no relationship.

The correlation between ICL Israel's Price To Sales Ratio and Payout Ratio is 0.05. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Payout Ratio in the same time period over historical financial statements of ICL Israel Chemicals, assuming nothing else is changed. The correlation between historical values of ICL Israel's Price To Sales Ratio and Payout Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of ICL Israel Chemicals are associated (or correlated) with its Payout Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Payout Ratio has no effect on the direction of Price To Sales Ratio i.e., ICL Israel's Price To Sales Ratio and Payout Ratio go up and down completely randomly.

Correlation Coefficient

0.05

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Price To Sales Ratio

Price to Sales Ratio is figured by comparing ICL Israel Chemicals stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on ICL Israel sales, a figure that is much harder to manipulate than other ICL Israel Chemicals multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Payout Ratio

Payout Ratio is the proportion of ICL Israel Chemicals earnings paid out as dividends to shareholders. Payout Ratio is typically expressed as a percentage but can be shown as dividends paid out as a proportion of cash flow. The payout ratio is used to determine the sustainability of ICL Israel Chemicals dividend payments. A lower payout ratio is generally preferable to a higher payout ratio, with a ratio greater than 100% indicating ICL Israel Chemicals is paying out more in dividends than it makes in net income.

Most indicators from ICL Israel's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ICL Israel Chemicals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICL Israel Chemicals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

At this time, ICL Israel's Selling General Administrative is quite stable compared to the past year. Sales General And Administrative To Revenue is expected to rise to 0.07 this year, although the value of Tax Provision will most likely fall to about 309.6 M.

	2021	2022	2023	2024 (projected)
Interest Expense	216M	327M	160M	119.6M
Depreciation And Amortization	523.9M	481.2M	536M	273.3M

Interest Expense Depreciation And Amortization

ICL Israel fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt
Total Assets		0.7	0.53	0.95	0.92	0.93	0.55	0.77	0.95	0.56	0.96	0.42	0.64	0.76	0.96	0.46	0.4	0.35	0.76	0.86	0.58	0.09	0.89	0.65	0.85	0.62
Short Long Term Debt Total	0.7		0.62	0.69	0.36	0.66	0.98	0.3	0.62	0.03	0.77	0.38	0.06	0.42	0.7	0.13	0.24	-0.09	0.97	0.44	0.42	-0.06	0.94	0.24	0.4	0.59
Other Current Liab	0.53	0.62		0.5	0.35	0.68	0.6	0.34	0.41	0.07	0.63	-0.22	0.0	0.16	0.58	0.16	0.11	-0.34	0.61	0.28	0.58	0.63	0.61	0.51	0.23	0.24
Total Current Liabilities	0.95	0.69	0.5		0.84	0.85	0.54	0.71	0.95	0.59	0.89	0.38	0.66	0.75	0.95	0.47	0.39	0.36	0.71	0.83	0.67	0.07	0.88	0.65	0.85	0.74
Total Stockholder Equity	0.92	0.36	0.35	0.84		0.85	0.19	0.84	0.88	0.68	0.83	0.33	0.78	0.77	0.86	0.56	0.38	0.52	0.44	0.88	0.47	0.14	0.63	0.69	0.88	0.51
Property Plant And Equipment Net	0.93	0.66	0.68	0.85	0.85		0.55	0.72	0.85	0.4	0.98	0.27	0.45	0.52	0.89	0.46	0.33	0.16	0.72	0.67	0.56	0.36	0.82	0.65	0.64	0.58
Net Debt	0.55	0.98	0.6	0.54	0.19	0.55		0.16	0.45	-0.17	0.67	0.32	-0.15	0.26	0.54	0.04	0.18	-0.22	0.93	0.27	0.31	-0.06	0.85	0.1	0.2	0.53
Retained Earnings	0.77	0.3	0.34	0.71	0.84	0.72	0.16		0.74	0.77	0.7	0.26	0.65	0.64	0.71	0.74	0.8	0.51	0.37	0.74	0.38	0.3	0.53	0.89	0.73	0.41
Accounts Payable	0.95	0.62	0.41	0.95	0.88	0.85	0.45	0.74		0.65	0.88	0.47	0.72	0.78	0.93	0.37	0.4	0.35	0.68	0.86	0.62	0.06	0.84	0.65	0.88	0.55
Cash	0.56	0.03	0.07	0.59	0.68	0.4	-0.17	0.77	0.65		0.37	0.18	0.91	0.64	0.59	0.57	0.6	0.59	0.11	0.69	0.46	0.14	0.31	0.81	0.78	0.17
Non Current Assets Total	0.96	0.77	0.63	0.89	0.83	0.98	0.67	0.7	0.88	0.37		0.39	0.44	0.59	0.91	0.43	0.35	0.18	0.82	0.71	0.52	0.2	0.91	0.58	0.67	0.64
Non Currrent Assets Other	0.42	0.38	-0.22	0.38	0.33	0.27	0.32	0.26	0.47	0.18	0.39		0.33	0.36	0.29	0.05	0.28	0.48	0.45	0.4	0.0	-0.51	0.46	-0.06	0.38	0.3
Cash And Short Term Investments	0.64	0.06	0.0	0.66	0.78	0.45	-0.15	0.65	0.72	0.91	0.44	0.33		0.74	0.66	0.5	0.33	0.72	0.14	0.77	0.46	-0.07	0.36	0.62	0.88	0.27
Net Receivables	0.76	0.42	0.16	0.75	0.77	0.52	0.26	0.64	0.78	0.64	0.59	0.36	0.74		0.78	0.41	0.37	0.54	0.46	0.93	0.32	-0.26	0.61	0.5	0.93	0.38
Good Will	0.96	0.7	0.58	0.95	0.86	0.89	0.54	0.71	0.93	0.59	0.91	0.29	0.66	0.78		0.49	0.34	0.26	0.73	0.84	0.56	0.16	0.87	0.7	0.84	0.59
Common Stock Total Equity	0.46	0.13	0.16	0.47	0.56	0.46	0.04	0.74	0.37	0.57	0.43	0.05	0.5	0.41	0.49		0.61	0.58	0.09	0.37	0.01	0.29	0.24	0.72	0.43	0.49
Common Stock Shares Outstanding	0.4	0.24	0.11	0.39	0.38	0.33	0.18	0.8	0.4	0.6	0.35	0.28	0.33	0.37	0.34	0.61		0.41	0.28	0.4	0.18	0.12	0.35	0.69	0.4	0.25
Short Term Investments	0.35	-0.09	-0.34	0.36	0.52	0.16	-0.22	0.51	0.35	0.59	0.18	0.48	0.72	0.54	0.26	0.58	0.41		-0.06	0.49	0.09	-0.38	0.1	0.29	0.59	0.33
Non Current Liabilities Total	0.76	0.97	0.61	0.71	0.44	0.72	0.93	0.37	0.68	0.11	0.82	0.45	0.14	0.46	0.73	0.09	0.28	-0.06		0.51	0.48	-0.06	0.96	0.28	0.47	0.48
Inventory	0.86	0.44	0.28	0.83	0.88	0.67	0.27	0.74	0.86	0.69	0.71	0.4	0.77	0.93	0.84	0.37	0.4	0.49	0.51		0.49	-0.13	0.68	0.59	0.97	0.44
Other Current Assets	0.58	0.42	0.58	0.67	0.47	0.56	0.31	0.38	0.62	0.46	0.52	0.0	0.46	0.32	0.56	0.01	0.18	0.09	0.48	0.49		0.22	0.59	0.49	0.56	0.32
Other Stockholder Equity	0.09	-0.06	0.63	0.07	0.14	0.36	-0.06	0.3	0.06	0.14	0.2	-0.51	-0.07	-0.26	0.16	0.29	0.12	-0.38	-0.06	-0.13	0.22		-0.02	0.58	-0.14	-0.07
Total Liab	0.89	0.94	0.61	0.88	0.63	0.82	0.85	0.53	0.84	0.31	0.91	0.46	0.36	0.61	0.87	0.24	0.35	0.1	0.96	0.68	0.59	-0.02		0.45	0.66	0.62
Property Plant And Equipment Gross	0.65	0.24	0.51	0.65	0.69	0.65	0.1	0.89	0.65	0.81	0.58	-0.06	0.62	0.5	0.7	0.72	0.69	0.29	0.28	0.59	0.49	0.58	0.45		0.62	0.29
Total Current Assets	0.85	0.4	0.23	0.85	0.88	0.64	0.2	0.73	0.88	0.78	0.67	0.38	0.88	0.93	0.84	0.43	0.4	0.59	0.47	0.97	0.56	-0.14	0.66	0.62		0.44
Short Term Debt	0.62	0.59	0.24	0.74	0.51	0.58	0.53	0.41	0.55	0.17	0.64	0.3	0.27	0.38	0.59	0.49	0.25	0.33	0.48	0.44	0.32	-0.07	0.62	0.29	0.44

Click cells to compare fundamentals

ICL Israel Account Relationship Matchups

ICL Israel fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	9.2B	9.7B	11.1B	11.8B	11.6B	7.7B
Short Long Term Debt Total	2.6B	2.8B	3.0B	2.8B	2.7B	2.2B
Other Current Liab	587M	654M	755M	970M	689.4M	507.1M
Total Current Liabilities	1.8B	2.2B	2.6B	2.6B	2.6B	1.9B
Total Stockholder Equity	3.9B	3.9B	4.5B	5.5B	5.8B	3.1B
Property Plant And Equipment Net	5.2B	5.6B	5.8B	6.0B	6.3B	3.7B
Net Debt	2.5B	2.6B	2.5B	2.4B	2.3B	2.0B
Retained Earnings	3.9B	3.8B	4.3B	5.4B	5.6B	5.9B
Accounts Payable	712M	740M	1.1B	1.0B	912M	633.8M
Cash	95M	214M	473M	417M	420M	441M
Non Current Assets Total	6.5B	6.8B	7.2B	7.2B	7.6B	4.8B
Non Currrent Assets Other	353M	393M	279.8M	228M	237M	229.3M
Cash And Short Term Investments	191M	314M	564M	508M	592M	325.7M
Net Receivables	1.2B	883M	1.4B	1.8B	1.6B	1.2B
Good Will	302M	320M	502M	507M	530M	266.3M
Common Stock Shares Outstanding	1.3B	1.3B	1.3B	1.3B	1.3B	1.4B
Short Term Investments	92M	96M	100M	91M	172M	127.5M
Liabilities And Stockholders Equity	9.2B	9.7B	11.1B	11.8B	11.6B	7.7B
Non Current Liabilities Total	3.4B	3.4B	3.7B	3.4B	3.0B	2.6B
Inventory	1.3B	1.3B	1.6B	2.1B	1.7B	1.3B
Other Current Assets	51M	275M	357M	323M	122M	122.5M
Other Stockholder Equity	(62M)	(56M)	(36M)	(27M)	(26M)	(24.7M)
Total Liab	5.1B	5.6B	6.3B	6.0B	5.6B	4.5B
Property Plant And Equipment Gross	5.3B	5.6B	12.5B	13.0B	13.8B	14.5B
Total Current Assets	2.7B	2.8B	3.9B	4.5B	4.0B	2.9B
Accumulated Other Comprehensive Income	(439M)	(312M)	(306M)	(443M)	(338M)	(354.9M)
Short Term Debt	420M	679M	577M	580M	858M	540.4M
Current Deferred Revenue	42M	17M	33M	41M	10M	9.5M
Intangible Assets	332M	336M	365M	345M	343M	403.7M
Other Liab	1.2B	1.3B	1.3B	1.1B	1.3B	1.1B
Other Assets	362M	309M	378M	524M	434.7M	384.2M
Long Term Debt	2.2B	2.1B	2.4B	2.3B	1.6B	2.3B
Property Plant Equipment	5.3B	5.6B	5.8B	6.0B	6.9B	5.1B
Net Tangible Assets	3.3B	3.3B	3.7B	4.6B	5.3B	3.1B
Long Term Investments	140M	83M	26M	3M	2M	1.9M
Short Long Term Debt	371M	684M	577M	512M	786M	523.7M
Long Term Debt Total	1.8B	2.2B	2.1B	2.4B	2.2B	1.9B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether ICL Israel Chemicals is a strong investment it is important to analyze ICL Israel's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ICL Israel's future performance. For an informed investment choice regarding ICL Stock, refer to the following important reports:

How To Invest In ICL

Details

Is ICL Stock a good investment?

Details

What is ICL Israel's Net Worth?

Details

Largest Agricultural Inputs Companies

View

Largest Basic Materials Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICL Israel Chemicals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Is Fertilizers & Agricultural Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICL Israel. If investors know ICL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICL Israel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.18)

Dividend Share

0.2

Earnings Share

0.31

Revenue Per Share

5.373

Quarterly Revenue Growth

(0.06)

The market value of ICL Israel Chemicals is measured differently than its book value, which is the value of ICL that is recorded on the company's balance sheet. Investors also form their own opinion of ICL Israel's value that differs from its market value or its book value, called intrinsic value, which is ICL Israel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICL Israel's market value can be influenced by many factors that don't directly affect ICL Israel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between ICL Israel's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICL Israel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICL Israel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

ICL Price To Sales Ratio vs Payout Ratio Analysis

Price To Sales Ratio vs Payout Ratio

Price To Sales Ratio vs Payout Ratio Correlation Analysis

Correlation Coefficient

Price To Sales Ratio

Payout Ratio

ICL Israel fundamental ratios Correlations

ICL Israel Account Relationship Matchups

High Positive Relationship

High Negative Relationship

ICL Israel fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Debt	+ 0.98	Short Long Term Debt Total
Non Current Assets Total	+ 0.98	Property Plant And Equipment Net
Non Current Liabilities Total	+ 0.97	Short Long Term Debt Total
Total Current Assets	+ 0.97	Inventory
Non Current Assets Total	+ 0.96	Total Assets
Good Will	+ 0.96	Total Assets

Other Stockholder Equity	- 0.51	Non Currrent Assets Other
Other Stockholder Equity	- 0.38	Short Term Investments
Short Term Investments	- 0.34	Other Current Liab
Other Stockholder Equity	- 0.26	Net Receivables
Short Term Investments	- 0.22	Net Debt
Non Currrent Assets Other	- 0.22	Other Current Liab